Daily BriefsECM

Daily Brief ECM: Nippon Express (9147 JP): The Current Playbook and more

In today’s briefing:

  • Nippon Express (9147 JP): The Current Playbook
  • Classys: One of Korea’s Top Beauty Medical Device Makers + Higher Shares Cancellation and Dividends
  • Astera Labs IPO Valuation Update: Multiples Appear Rich, Limited Post-IPO Upside
  • Shanghai Zhida Technology Development Pre-IPO Tearsheet


Nippon Express (9147 JP): The Current Playbook

By Arun George

  • Since the US$260 million secondary placement announcement, Nippon Express Holdings (9147 JP) shares are down 5.3% from the undisturbed price of JPY8,039 per share (1 March).
  • Looking at recent large Japanese placements is instructive to understand the potential trading pattern. So far, Nippon Express shares have followed the pattern of previous large placements.
  • The offering will likely be priced on 11 March. Investors who have participated in previous large Japanese placements tend to secure positive returns.

Classys: One of Korea’s Top Beauty Medical Device Makers + Higher Shares Cancellation and Dividends

By Douglas Kim

  • Classys is one of the top beauty medical device companies in Korea. Classys’ main products include Shurink Universe and Volnewmer.
  • We have a positive view of Classys (214150 KS). Classys is trading at relatively reasonable valuations, considering the company’s strong growth in sales and profits.
  • On 28 February, Classys announced a shareholder return amount of 38 billion won (including share cancellation of about 25 billion won and dividend payout of 13 billion won).

Astera Labs IPO Valuation Update: Multiples Appear Rich, Limited Post-IPO Upside

By Andrei Zakharov

  • Astera Labs, which offers connectivity solutions tailored for AI accelerators, GPUs, FPGAs and other high-performance computing platforms, announced terms for its IPO today.
  • California-Based semiconductor company plans to raise ~$392M by offering ~14.8M shares at a price range of $27 to $30. Selling stockholders offer ~3M shares of common stock in this IPO.  
  • At the midpoint of the proposed price range, Astera Labs would command a fully diluted market value of $5B, above their last private round of $3.15B.

Shanghai Zhida Technology Development Pre-IPO Tearsheet

By Clarence Chu

  • Shanghai Zhida Technology Development Co Ltd (SZTD HK) is looking to raise about US$130m in its upcoming Hong Kong IPO. Shenwan Hongyuan is the sole bookrunner.
  • Shanghai Zhida Technology Development (SZTD) is a provider of electric vehicle (EV) home charging solutions.
  • As per F&S, the firm was the world’s largest provider of EV home charging solutions in terms of sales volume of home EV chargers over its track record period.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars